Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/29/2008CN100428935C Abiduoer granular formulation
10/29/2008CN100428934C Application of cumarin kind compound in preparation of medicine for inducing nerve stem cell orienting differentiation
10/29/2008CN100428933C Use of opc in preparing medicine for treating and preventing senile dementia
10/29/2008CN100428932C TGF-alpha expression inhibitors
10/29/2008CN100428931C Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method
10/29/2008CN100428930C Application of p-hydroxybenzoic acid and its analogue in the preparing process of medicine for preventing and treating skin mucous membrane virus infection
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442839 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant
10/28/2008US7442838 Polymorphic forms of sertraline hydrochloride
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442832 Painless injectable compositions containing salts of 2-arylpropionic acids
10/28/2008US7442830 Proteasome inhibitors
10/28/2008US7442829 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/28/2008US7442808 e.g. 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline; with other active ingredients; agonists of G-protein coupled receptor 40 (GPR40); antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperlipemia
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
10/28/2008US7442805 Substituted sulfonamide-indoles
10/28/2008US7442804 heating under microwave irradiation (3-hydroxymethylene-4-carboxylic acid ester-2-one)pyrroline derivatives in presence of inert solvent to produce 3,6-diphenylfuro[3,4-c]pyrrole-1,4-diones (furopyrroles); intermediates in process for preparation of diketopyrrolopyrroles; high yield and purity
10/28/2008US7442802 e.g. 1-(1-cyclohexyl-5-(4-(methylsulfonyl)phenyl)pyrazol-3-yl)-4-hydroxybutan-1-one; antiinflammatory agent, analgesic, antipyretic, wound healing agents; gastrointestinal disorders; side effect reduction
10/28/2008US7442796 oxo-acids such as [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, used for treating insulin resistance, diabetes, hyperlipemia, liver disorders, cachexia, obesity, atherosclerosis and arteriosclerosis
10/28/2008US7442792 halogenation of pyrazolo[1,5-a][1,3,5]triazin-4-ol's, with phosphorus oxyhalides, then dehalogenation and amination to yield dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine's, used as corticotropin releasing factor (CRF) receptor antagonists; anxiolytic agents; antidepressants
10/28/2008US7442791 Aminoalkylamide substituted cyclohexyl derivatives
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442781 Diagnosis, prevention and treatment of cancer
10/28/2008US7442761 Coronavirus amino acid sequences for use in prevention and treatment of infection and cell proliferative disorders
10/28/2008US7442720 concurrent administration of cysteamine hydrochloride with metformin
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442718 Inhibitors of aspartyl protease
10/28/2008US7442717 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure
10/28/2008US7442716 e.g. 2-[9-chloro-6-(3-hydroxy-3-methylbutyl-1-yn-1-yl)-1H-phenanthro[9,10-d]imidazol-2-yl]-3-fluorobenzonitrile; microsomal prostaglandin E synthase inhibitor; analgesic, antiinflammatory agent; osteoarthritis, rheumatoid arthritis and acute or chronic pain; side effect reducer
10/28/2008US7442715 Thiazole derivatives
10/28/2008US7442714 3-ethyl-5-methyl-2-(2-aminoethoxy-methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridine dicarboxylate gentisate; crystalline acid salt; low toxicity, excellent stability, improved pharmaceutical efficacies and long-lasting concentration in blood; cardiovascular diseases, hypotensive agent
10/28/2008US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics
10/28/2008US7442712 Constrained himbacine analogs as thrombin receptor antagonists
10/28/2008US7442711 Amelioration of the development of cataracts and other ophthalmic diseases
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442709 c-Kit proto-oncogene inhibitors(KIT, CD-117, stem cell or mast cell growth factor receptor); anticancer; better selectivity, potency, reduced toxicity, side effects; leukemias; angiogenesis; 3-{3-[(4-(Trifluoromethoxy)benzyl)oxy]phenyl}-N-(pyridine-3-ylmethyl)-3H-imidazo[4,5-b]pyridine-6-carboxamide
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442707 provides CCI-779 polymorph Form II. This invention also provides processes for preparing CCI-779 polymorph Form II and pharmaceutical compositions including CCI-779 polymorph Form II.
10/28/2008US7442706 methods for treating sarcopenia with a growth hormone secretagogue.or increasing muscle mass to treat sarcopenia, comprising: administering to a patient in need thereof a therapeutically effective amount of a growth hormone secretagogue.
10/28/2008US7442705 HIV replication inhibiting pyrimidines and triazines
10/28/2008US7442704 Amide derivatives
10/28/2008US7442703 Piperidine derivatives useful as CCR5 antagonists
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442701 Amino-heterocycles as VR-1 antagonists for treating pain
10/28/2008US7442700 N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1f][1,2,4]triazin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; allergies and asthma, Alzheimer's disease, rheumatoid arthritis, autoimmune diseases, bone diseases, inflammation
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008US7442696 5-Chloro-6-(3-cyanophenyl)-1,4-dihydro-4,4-dimethyl-2H-3,1-benzoxazin-2-one; congestive heart failure, hypertension, fibrosis, hyperaldosteronism, hypokalemia, liver cirrhosis, metabolic acidosis, hypoadrenocorticoidism, and Addison's disease; 3,1-benzoxazin-2-one derivatives
10/28/2008US7442695 Depeptidized inhibitors of hepatitis C virus NS3 protease
10/28/2008US7442694 Diazabicyclic compounds useful in the treatment of CNS and other disorders
10/28/2008US7442693 Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
10/28/2008US7442692 Indanyl-piperazine compounds
10/28/2008US7442691 Macrocycles useful in the treatment of alzheimer's disease
10/28/2008US7442690 Topical treatment for psoriasis
10/28/2008US7442689 Cardioprotective phosphonates and malonates
10/28/2008US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
10/28/2008US7442687 2-polycyclic propynyl adenosine analogs having A2A agonist activity
10/28/2008US7442680 Inotropic and diuretic effects of GLP-1 and GLP-1 agonists
10/28/2008US7442672 Applying to plants
10/28/2008US7442671 O-phenylphenol/alkoxylated amine wood protection compositions
10/28/2008US7442573 Scaffold-organized clusters and electronic devices made using such clusters
10/28/2008US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy
10/28/2008US7442541 biologically pure strain of Aureobasidium pullulans isolated from a food source; culturing in a medium containing saccharides as a carbon source; has resistance to the antibiotic cycloheximide
10/28/2008US7442387 Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442385 Chemoembolisation
10/28/2008US7442384 Bioresorbable hydrogel compositions for implantable prostheses
10/28/2008US7442380 Treatment of diseases caused by viral infection
10/28/2008US7442377 Protective antigen of epstein barr virus
10/28/2008US7442370 Polymer conjugates of mutated neublastin
10/28/2008US7442369 Compositions of minoxidil
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008US7442142 Automatic transmission
10/28/2008CA2556520C Chromium-fatty acid compounds and methods of making and using thereof
10/28/2008CA2556514C Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/28/2008CA2524300C Modified-release tablet of bupropion hydrochloride
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2442227C Ccr5 antagonists useful for treating aids
10/28/2008CA2423286C Amorphous form of cell cycle inhibitor
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2380452C Imidazo-triazine derivatives as ligands for gaba receptors
10/28/2008CA2359027C S-nitrosothiols as agents for the treatment of circulatory dysfunctions
10/28/2008CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
10/28/2008CA2355857C 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
10/28/2008CA2353956C Remedial agent for erectile dysfunction
10/28/2008CA2342102C Tan-1057 derivatives
10/28/2008CA2339218C Methods and compositions for increasing insulin sensitivity
10/28/2008CA2337227C Emollient esters based upon capryl alcohol and isostearic acid
10/28/2008CA2335472C Processes to generate submicron particles of water-insoluble compounds
10/28/2008CA2331141C Water soluble azoles as broad-spectrum antifungals
10/28/2008CA2315767C Autoclavable pharmaceutical compositions containing a chelating agent
10/28/2008CA2300876C Naphthoquinone derivatives as hiv matrix protein tyrosine position 29 pocket binders
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/28/2008CA2291160C Combination therapy for modulating the human sexual response
1 ... 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 ... 7860